Cargando…

The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective

Diabetes has reached worldwide epidemic proportions, and threatens to be a significant economic burden to both patients and healthcare systems, and an important driver of cardiovascular mortality and morbidity. Improvement in lifestyle interventions (which includes increase in physical activity via...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Jose A., Uryash, Arkady, Lopez, Jose R., Sackner, Marvin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940370/
https://www.ncbi.nlm.nih.gov/pubmed/33708143
http://dx.doi.org/10.3389/fphys.2021.638491
_version_ 1783661939214254080
author Adams, Jose A.
Uryash, Arkady
Lopez, Jose R.
Sackner, Marvin A.
author_facet Adams, Jose A.
Uryash, Arkady
Lopez, Jose R.
Sackner, Marvin A.
author_sort Adams, Jose A.
collection PubMed
description Diabetes has reached worldwide epidemic proportions, and threatens to be a significant economic burden to both patients and healthcare systems, and an important driver of cardiovascular mortality and morbidity. Improvement in lifestyle interventions (which includes increase in physical activity via exercise) can reduce diabetes and cardiovascular disease mortality and morbidity. Encouraging a population to increase physical activity and exercise is not a simple feat particularly in individuals with co-morbidities (obesity, heart disease, stroke, peripheral vascular disease, and those with cognitive and physical limitations). Translation of the physiological benefits of exercise within that vulnerable population would be an important step for improving physical activity goals and a stopgap measure to exercise. In large part many of the beneficial effects of exercise are due to the introduction of pulsatile shear stress (PSS) to the vascular endothelium. PSS is a well-known stimulus for endothelial homeostasis, and induction of a myriad of pathways which include vasoreactivity, paracrine/endocrine function, fibrinolysis, inflammation, barrier function, and vessel growth and formation. The endothelial cell mediates the balance between vasoconstriction and relaxation via the major vasodilator endothelial derived nitric oxide (eNO). eNO is critical for vasorelaxation, increasing blood flow, and an important signaling molecule that downregulates the inflammatory cascade. A salient feature of diabetes, is endothelial dysfunction which is characterized by a reduction of the bioavailability of vasodilators, particularly nitric oxide (NO). Cellular derangements in diabetes are also related to dysregulation in Ca(2+) handling with increased intracellular Ca(2+)overload, and oxidative stress. PSS increases eNO bioavailability, reduces inflammatory phenotype, decreases intracellular Ca(2+) overload, and increases antioxidant capacity. This narrative review and perspective will outline four methods to non-invasively increase PSS; Exercise (the prototype for increasing PSS), Enhanced External Counterpulsation (EECP), Whole Body Vibration (WBV), Passive Simulated Jogging and its predicate device Whole Body Periodic Acceleration, and will discuss current knowledge on their use in diabetes.
format Online
Article
Text
id pubmed-7940370
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79403702021-03-10 The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective Adams, Jose A. Uryash, Arkady Lopez, Jose R. Sackner, Marvin A. Front Physiol Physiology Diabetes has reached worldwide epidemic proportions, and threatens to be a significant economic burden to both patients and healthcare systems, and an important driver of cardiovascular mortality and morbidity. Improvement in lifestyle interventions (which includes increase in physical activity via exercise) can reduce diabetes and cardiovascular disease mortality and morbidity. Encouraging a population to increase physical activity and exercise is not a simple feat particularly in individuals with co-morbidities (obesity, heart disease, stroke, peripheral vascular disease, and those with cognitive and physical limitations). Translation of the physiological benefits of exercise within that vulnerable population would be an important step for improving physical activity goals and a stopgap measure to exercise. In large part many of the beneficial effects of exercise are due to the introduction of pulsatile shear stress (PSS) to the vascular endothelium. PSS is a well-known stimulus for endothelial homeostasis, and induction of a myriad of pathways which include vasoreactivity, paracrine/endocrine function, fibrinolysis, inflammation, barrier function, and vessel growth and formation. The endothelial cell mediates the balance between vasoconstriction and relaxation via the major vasodilator endothelial derived nitric oxide (eNO). eNO is critical for vasorelaxation, increasing blood flow, and an important signaling molecule that downregulates the inflammatory cascade. A salient feature of diabetes, is endothelial dysfunction which is characterized by a reduction of the bioavailability of vasodilators, particularly nitric oxide (NO). Cellular derangements in diabetes are also related to dysregulation in Ca(2+) handling with increased intracellular Ca(2+)overload, and oxidative stress. PSS increases eNO bioavailability, reduces inflammatory phenotype, decreases intracellular Ca(2+) overload, and increases antioxidant capacity. This narrative review and perspective will outline four methods to non-invasively increase PSS; Exercise (the prototype for increasing PSS), Enhanced External Counterpulsation (EECP), Whole Body Vibration (WBV), Passive Simulated Jogging and its predicate device Whole Body Periodic Acceleration, and will discuss current knowledge on their use in diabetes. Frontiers Media S.A. 2021-02-23 /pmc/articles/PMC7940370/ /pubmed/33708143 http://dx.doi.org/10.3389/fphys.2021.638491 Text en Copyright © 2021 Adams, Uryash, Lopez and Sackner. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Adams, Jose A.
Uryash, Arkady
Lopez, Jose R.
Sackner, Marvin A.
The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective
title The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective
title_full The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective
title_fullStr The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective
title_full_unstemmed The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective
title_short The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective
title_sort endothelium as a therapeutic target in diabetes: a narrative review and perspective
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940370/
https://www.ncbi.nlm.nih.gov/pubmed/33708143
http://dx.doi.org/10.3389/fphys.2021.638491
work_keys_str_mv AT adamsjosea theendotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT uryasharkady theendotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT lopezjoser theendotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT sacknermarvina theendotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT adamsjosea endotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT uryasharkady endotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT lopezjoser endotheliumasatherapeutictargetindiabetesanarrativereviewandperspective
AT sacknermarvina endotheliumasatherapeutictargetindiabetesanarrativereviewandperspective